Alkylating analogues of the tumour inhibitor 5-aziridino-2,4-dinitrobenzamide.
D000477:Alkylating Agents; D000478:Alkylation; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001389:Azirines / Q000138:chemical synthesis* / Q000627:therapeutic use; D001565:Benzoates / Q000138:chemical synthesis* / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D006868:Hydrolysis; D007928:Lethal Dose 50; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009574:Nitro Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001389:Azirines; D001565:Benzoates; D009574:Nitro Compounds